Supplemental Annuity Collective Trust of NJ - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
Supplemental Annuity Collective Trust of NJ ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$375,760
-11.3%
11,0000.0%0.14%
-7.2%
Q2 2023$423,500
+7.6%
11,0000.0%0.15%
-1.3%
Q1 2023$393,690
-9.2%
11,0000.0%0.15%
-14.4%
Q4 2022$433,730
+9.3%
11,0000.0%0.18%
+4.0%
Q3 2022$397,000
+18.5%
11,0000.0%0.17%
+29.1%
Q2 2022$335,000
-0.3%
11,0000.0%0.13%
+21.8%
Q1 2022$336,000
-2.3%
11,0000.0%0.11%
+4.8%
Q4 2021$344,000
+104.8%
11,0000.0%0.10%
+90.9%
Q3 2021$168,000
-18.0%
11,0000.0%0.06%
-16.7%
Q2 2021$205,000
+4.1%
11,0000.0%0.07%
-2.9%
Q1 2021$197,000
+16.6%
11,0000.0%0.07%
+7.9%
Q4 2020$169,000
+38.5%
11,0000.0%0.06%
+23.5%
Q3 2020$122,000
-11.6%
11,0000.0%0.05%
-19.0%
Q2 2020$138,000
+10.4%
11,0000.0%0.06%
-8.7%
Q1 2020$125,000
-13.2%
11,0000.0%0.07%
+15.0%
Q4 2019$144,000
+45.5%
11,0000.0%0.06%
+33.3%
Q3 2019$99,00011,0000.04%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 850,000$15,215,0003.58%
ACUTA CAPITAL PARTNERS, LLC 412,500$7,384,0002.66%
BVF INC/IL 3,481,778$62,324,0002.34%
Soleus Capital Management, L.P. 708,117$12,675,0002.28%
COMMODORE CAPITAL LP 301,392$5,395,0002.15%
DAFNA Capital Management LLC 406,535$7,277,0001.73%
Parkman Healthcare Partners LLC 374,395$6,702,0001.56%
Avoro Capital Advisors LLC 3,650,000$65,335,0001.13%
KNOTT DAVID M 144,101$2,579,0001.10%
Orbimed Advisors 2,497,917$44,713,0000.42%
View complete list of XENON PHARMACEUTICALS INC shareholders